MOUNTAIN VIEW, Calif., Oct. 3, 2016 /PRNewswire/ -- Based on its recent analysis of the prothrombin time/international normalized ratio (PT/INR) coagulation point of care (POC) market, Frost & Sullivan recognizes iLine Microsystems with the 2016 European Award for Enabling Technology Leadership. iLine Microsystems' microINR system is poised to disrupt the POC PT/INR testing space with its lab on chip (LOC) approach. The device's scalability and reliability, along with its ease of handling and multifunction quality control (QC) steps, make it the most cost-effective device for oral anticoagulant therapy (OAT) monitoring.
"The microINR system showcases iLine Microsystems' expertise in hemostasis by employing LOC technology and applying microfluidics in the POC PT/INR testing space for both near patient testing and patient self-testing," said Frost & Sullivan Senior Industry Analyst Divyaa Ravishankar. "This approach enables the integration of distinct biochemical tests in various channels within a single chip design, so that each channel has all the functionalities required to catalyze a reaction."
The modular and integrated design of the microINR system comprises two components: a disposable microINR chip and a microINR meter. While the chip is used to hold the sample and the calibration information, the meter performs QC check and calibration reading. Additional Control checks are run in parallel to ensure test reliability, and results are displayed within 1 minute. This patented transformational technology for INR testing can store 200 test results and error logs, and provides an USB interface for transferring results to a desktop or an electronic health record (EHR).
The microINR system's key benefits include:
- Microfluidic reaction. Microfluidics enable homogenous mixing by diffusion through the laminar flow generated by capillary reaction. Unlike peer devices and strips, the test is conducted under continuous blood flow.
- User friendliness. The process has minimal steps; for example, the device is automatically calibrated when the chip is inserted into the system, while all other INR devices require manual calibration.
- Low sample volume. The microINR is the only device that can function with a minimum sample volume of 3 μL by combining microfluidic principles with innovative chip design.
- Low reagent volume. The technology's unique customization potential and the in-house production line tactics to dispense nanoliters of reagents has reduced the overall cost of production while keeping the biochemical properties and the integrity of the diagnostic reaction intact.
Other advantages of the microINR system include individual foil packaging for each chip to reduce bacterial contamination and rigorous QC protocols. Overall, it functions as a portable coagulometer with an embedded machine vision system that can mimic conditions of in-vivo hemostasis.
"The CE-marked microINR system has been cleverly designed to meet the needs of both centralized and decentralized settings," Ravishankar said. "It enjoys huge popularity in key markets, and has gained very significant market share in Europe. Given the disruptive nature of its core technology, iLine Microsystems is looking to replicate its success in other POC market segments."
Each year, Frost & Sullivan presents this award to the company that has demonstrated uniqueness in developing and leveraging new technologies, which influences both the functionality and the customer value of the new products and applications. The award lauds the high research and development spend on innovation, its relevance to the industry, and the positive effect on brand perception.
Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.
About iLine Microsystems
iLine Microsystems has become a key player in the Point of Care diagnostic within the Hemostasis field after years of biomedical and biotechnological research and real market experience of proprietary Point of Care diagnostic solutions. iLine Microsystems was founded in 2007 with the aim to meet the needs of current and future healthcare models, improving the efficiency of healthcare professionals and patients' quality of life.
The company designs and manufactures innovative Point of Care medical devices on the hemostasis field exploiting the advantages of both microfluidics and Lab-on-a-Chip technological concepts under the company´s proprietary core technology.
P:+34 943 005651
F: +34 943 008737
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion.
P: +44 (0) 207.343.8314
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/frost--sullivan-applauds-iline-microsystems-for-developing-a-microfluidics-based-sophisticated-poc-device-for-ptinr-coagulation-testing-300337252.html
SOURCE Frost & Sullivan